CatalystIQDrug pipeline intelligence

Clinical and regulatory catalysts in one place.

CatalystIQ reads ClinicalTrials.gov, the FDA and the Orange Book directly, diffs every sweep, and turns the result into a catalyst calendar with the patent cliffs behind it. It is in open beta: the whole calendar is readable without an account. It is an information tool, not investment advice.

Open the dashboard See pricing

This sweep: 57 upcoming catalysts · 2283 patent cliffs inside 12 months · 22 recent FDA approvals · 13703 tracked trials.

Upcoming catalysts
57
Patent cliffs (12mo)
2283
Recent FDA approvals
22
Tracked trials
13703
Pharma headlines
60

Nearest catalysts

CompanyCatalystDate
GEN NewsNews catalyst2026-10-28
GEN NewsNews catalyst2026-10-28
BioPharma DiveNews catalyst2026-10-28
STAT NewsNews catalyst2026-10-28
BioPharma DiveNews catalyst2026-10-27
STAT NewsNews catalyst2026-10-27
FDA Press ReleasesNews catalyst2026-10-20
FDA Press ReleasesNews catalyst2026-10-20
FDA Press ReleasesNews catalyst2026-10-20
FDA Press ReleasesNews catalyst2026-10-19
FDA Press ReleasesNews catalyst2026-10-14
FDA Press ReleasesNews catalyst2026-10-01
FDA Press ReleasesNews catalyst2026-09-28
FDA Press ReleasesNews catalyst2026-09-17
FDA Press ReleasesNews catalyst2026-09-04
ACTELION PHARMACEUTICALS US INCUPTRAVI · Patent expiry2026-10-31
ACTELION PHARMACEUTICALS US INCUPTRAVI · Patent expiry2026-10-31
ACTELION PHARMACEUTICALS US INCUPTRAVI · Patent expiry2026-10-31
ACTELION PHARMACEUTICALS US INCUPTRAVI · Patent expiry2026-10-31
ACTELION PHARMACEUTICALS US INCUPTRAVI · Patent expiry2026-10-31
ACTELION PHARMACEUTICALS US INCUPTRAVI · Patent expiry2026-10-31
ACTELION PHARMACEUTICALS US INCUPTRAVI · Patent expiry2026-10-31
ACTELION PHARMACEUTICALS US INCUPTRAVI · Patent expiry2026-10-31
ACTELION PHARMACEUTICALS US INCUPTRAVI · Patent expiry2026-10-31
ACTELION PHARMACEUTICALS US INCUPTRAVI · Patent expiry2026-10-31
ACTELION PHARMACEUTICALS US INCUPTRAVI · Patent expiry2026-10-31
UPJOHN US 2 LLCLYRICA CR · Patent expiry2026-11-02
UPJOHN US 2 LLCLYRICA CR · Patent expiry2026-11-02
UPJOHN US 2 LLCLYRICA CR · Patent expiry2026-11-02
UPJOHN US 2 LLCLYRICA CR · Patent expiry2026-11-02
UPJOHN US 2 LLCLYRICA CR · Patent expiry2026-11-02
UPJOHN US 2 LLCLYRICA CR · Patent expiry2026-11-02
UPJOHN US 2 LLCLYRICA CR · Patent expiry2026-11-02
UPJOHN US 2 LLCLYRICA CR · Patent expiry2026-11-02
UPJOHN US 2 LLCLYRICA CR · Patent expiry2026-11-02
UPJOHN US 2 LLCLYRICA CR · Patent expiry2026-11-02
UPJOHN US 2 LLCLYRICA CR · Patent expiry2026-11-02
UPJOHN US 2 LLCLYRICA CR · Patent expiry2026-11-02
UPJOHN US 2 LLCLYRICA CR · Patent expiry2026-11-02
UPJOHN US 2 LLCLYRICA CR · Patent expiry2026-11-02
Open the dashboard

Showing the 40 nearest of 57 upcoming catalysts. The dashboard also includes trial records, FDA filings, patent data, research and news. Account features are limited to profile, consent and account-management tools; personal alerts and saved watchlists are not available.

How the sweep works

Three steps run on every sweep, and each one has a limit worth knowing before you rely on a number.

Primary sources

ClinicalTrials.gov, openFDA, FDA Orange Book, Google Patents, Europe PMC, configured news feeds and Yahoo Finance. Source coverage and availability vary.

Change detection

Sweeps are compared to previous runs to highlight changes in the fetched samples. Updates may be missed when records are outside the sampled window or an upstream source is unavailable.

Patent cliffs

Orange Book expiration and exclusivity records are presented as a research aid; confirm them against FDA records before relying on a date.